Cargando…
High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas
Background: Meningiomas are the most common primary central nervous system tumors. 20–30% of these tumors are considered high-grade and associated with poor prognosis and high recurrence rates. Despite the high occurrence of meningiomas, there are no FDA-approved compounds for the treatment of these...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303324/ https://www.ncbi.nlm.nih.gov/pubmed/34300316 http://dx.doi.org/10.3390/jcm10143150 |